Bajaj Healthcare Limited has informed the Exchange about General Updates
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bajaj Healthcare Limited has received listing approvals from both NSE and BSE for 20,79,409 equity shares of face value ₹5/- each. These shares were allotted upon conversion of convertible warrants issued on preferential basis to both Promoters and Non-Promoters. The shares were issued at a premium of ₹333/-, making the issue price ₹338 per share. The distinctive numbers for these shares range from 31583253 to 33662661. Trading approval will be granted after the company files confirmation letters from NSDL/CDSL regarding credit of shares to beneficiary accounts and lock-in compliance.
This issuance will dilute the existing shareholding as new equity shares are being listed. The conversion of warrants into equity increases the company's paid-up capital, which may have a minor negative impact on EPS for existing shareholders.